Copy to clipboard 
Oury Medical, manufacturer of medical instrumentation, has acquired Céfiméca, a manufacturer of orthopedic and spinal instruments and implants.
This transaction represents a new major step in the development of the Oury Medical group and is in line with the long-term industrial strategy initiated by TAG Partners at the time of the acquisition of Oury-Guyé three years ago. The acquisition of Céfiméca constitutes the fifth build-up operation carried out since the launch of this platform strategy.
Céfiméca brings expertise in orthopedic and spinal instruments, complemented by a focused and high-value range of implants. This combination strengthens Oury Medical’s position as a partner offering a fully integrated One-Stop-Shop offering for its clients in orthopedic medical instrumentation.
This acquisition is financed by TAG Partners and ISALT, an independent French asset management company, alongside several family offices and private investors.
With five production sites in France and a workforce of over 200 employees, Oury Medical further supports its ability to serve major players in orthopedics and spinal surgery.
Sébastien Meunier, Chief Executive Officer of Oury Medical Group, states: “This acquisition marks an important step in the execution of our strategy. By integrating complementary capabilities in instrumentation and focused and high-value range of implants, we further strengthen the value we bring to our clients, while remaining focused on our industrial DNA.”
Frédéric Mazenod, Chairman of Céfiméca, states: “For more than 25 years, Céfiméca has developed strong expertise in orthopedic and spinal instruments and implants. Joining Oury Medical allows us to leverage complementary capabilities and to continue our development within a broader and more ambitious industrial platform.”
Source: Oury Medical
